TAZOCIN Side Effects

7012474-0 | Haemoglobin Decreased, Rash Vesicular
on Sep 23, 2010 Male patient from UNITED KINGDOM , 34 years of age, weighting 227.1 lb, was diagnosed with sepsis (What is sepsis?), pain (What is pain?) and was treated with Tazocin (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, rash vesicular. Tazocin dosage: . During the same period patient was treated with MS CONTIN (View Ms Contin Review and Ms Contin Label ), PREGABALIN (View Pregabalin Review and Pregabalin Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ). Patient was hospitalized.

7007046-8 | Disseminated Intravascular Coagulation
Patient was taking Tazocin (View Usage). Patient had the following side effects: disseminated intravascular coagulation on Sep 20, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 89 years of age, was diagnosed with sepsis (What is sepsis?), gram stain negative, urinary tract infection (What is urinary tract infection?) and. Tazocin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), AMPICILLIN SODIUM/SULBACTAM SODIUM (View Ampicillin Sodium/sulbactam Sodium Review and Ampicillin Sodium/sulbactam Sodium Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), METFORMIN (View Metformin Review and Metformin Label ).

7005860-6 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dilatation Intrahepatic Duct Acquired
Adverse event was reported on Sep 17, 2010 by a Female patient taking Tazocin (View Usage) (Dosage: ) was diagnosed with pain (What is pain?) and. Location: UNITED KINGDOM , 19 years of age, After Tazocin was administered, patient had the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dilatation intrahepatic duct acquired. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CASPOFUNGIN ACETATE (View Caspofungin Acetate Review and Caspofungin Acetate Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), KETALAR (View Ketalar Review and Ketalar Label ), MORPHINE (View Morphine Review and Morphine Label ), NORETHIDRONE (View Norethidrone Review and Norethidrone Label ).

6977279-5 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dilatation Intrahepatic Duct Acquired
on Sep 01, 2010 Female patient from UNITED KINGDOM , 19 years of age, was diagnosed with pain (What is pain?) and was treated with Tazocin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dilatation intrahepatic duct acquired. Tazocin dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CASPOFUNGIN ACETATE (View Caspofungin Acetate Review and Caspofungin Acetate Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), KETALAR (View Ketalar Review and Ketalar Label ), MORPHINE (View Morphine Review and Morphine Label ), NORETHISTERONE (View Norethisterone Review and Norethisterone Label ).


6977233-3 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dilatation Intrahepatic Duct Acquired
on Sep 06, 2010 Female patient from UNITED KINGDOM , 19 years of age, was diagnosed with pain (What is pain?) and was treated with Tazocin (View Usage). Patient had the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dilatation intrahepatic duct acquired. Tazocin dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CASPOFUNGIN ACETATE (View Caspofungin Acetate Review and Caspofungin Acetate Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), KETALAR (View Ketalar Review and Ketalar Label ), MORPHINE (View Morphine Review and Morphine Label ), NORETHISTERONE (View Norethisterone Review and Norethisterone Label ).

6818273-4 | Accidental Exposure, Rash
Patient was taking Tazocin (View Usage). After Tazocin was administered, patient had the following side effects: accidental exposure, rash (What is rash?) on Jul 01, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 22 years of age, . Tazocin dosage: . Patient was hospitalized.

6809729-9 | Cyanosis, Hypertension, Shock
Adverse event was reported on Jun 22, 2010 by a Female patient taking Tazocin (View Usage) (Dosage: ) was diagnosed with sepsis (What is sepsis?) and. Location: BRAZIL , weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: cyanosis, hypertension, shock.

6756241-1 | Abdominal Abscess, Klebsiella Infection, Proteus Infection
on May 26, 2010 Male patient from CZECH REPUBLIC , 68 years of age, was diagnosed with infection (What is infection?) and was treated with Tazocin (View Usage). Patient had the following side effects: abdominal abscess, klebsiella infection, proteus infection. Tazocin dosage: . During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ).

6744659-2 | Eye Discharge, Hyperhidrosis, Laryngospasm, Nasal Congestion, Rash
on May 24, 2010 Male patient from MALAYSIA , 30 years of age, was diagnosed with postoperative wound infection and was treated with Tazocin (View Usage). After Tazocin was administered, patient had the following side effects: eye discharge, hyperhidrosis, laryngospasm, nasal congestion, rash (What is rash?). Tazocin dosage: One Dose.

6706307-7 | Laryngeal Oedema
Patient was taking Tazocin (View Usage). Patient experienced the following unwanted or unexpected effects: laryngeal oedema on Apr 29, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 70 years of age, weighting 246.9 lb, was diagnosed with cellulitis (What is cellulitis?), hypertension, thrombosis prophylaxis, hyperthyroidism, blood potassium decreased, hypercholesterolaemia and. Tazocin dosage: . During the same period patient was treated with BENZYLPENICILLIN (View Benzylpenicillin Review and Benzylpenicillin Label ), DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), TINZAPARIN SODIUM (View Tinzaparin Sodium Review and Tinzaparin Sodium Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SANDO K (View Sando K Review and Sando K Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ).

6659545-6 | Rash, Swelling
Adverse event was reported on Mar 29, 2010 by a Female patient taking Tazocin (View Usage) (Dosage: ) was diagnosed with infection (What is infection?), glaucoma (What is glaucoma?) and. Location: UNITED KINGDOM , 70 years of age, Patient had the following side effects: rash (What is rash?), swelling. During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), XALATAN (View Xalatan Review and Xalatan Label ), DF118 (View Df118 Review and Df118 Label ), FLOXACILLIN SODIUM (View Floxacillin Sodium Review and Floxacillin Sodium Label ), NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ), BENZYLPENICILLIN (View Benzylpenicillin Review and Benzylpenicillin Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ). Patient was hospitalized.

6601868-0 | Dysstasia, Muscular Weakness, Myalgia
on Feb 19, 2010 Male patient from UNITED KINGDOM , 67 years of age, was diagnosed with oesophageal operation, pain (What is pain?) and was treated with Tazocin (View Usage). After Tazocin was administered, patient had the following side effects: dysstasia, muscular weakness, myalgia. Tazocin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), TINZAPARIN SODIUM (View Tinzaparin Sodium Review and Tinzaparin Sodium Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ).

6596889-0 | Dysstasia, Myalgia
on Feb 19, 2010 Male patient from UNITED KINGDOM , 67 years of age, was diagnosed with oesophageal operation and was treated with Tazocin (View Usage). Patient experienced the following unwanted or unexpected effects: dysstasia, myalgia. Tazocin dosage: . During the same period patient was treated with CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), TINZAPARIN SODIUM (View Tinzaparin Sodium Review and Tinzaparin Sodium Label ), GLYCERYL TRINITRATE (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ).

6570881-4 | Multi-organ Failure, Septic Shock
Patient was taking Tazocin (View Usage). Patient had the following side effects: multi-organ failure, septic shock on Jan 26, 2010 from PORTUGAL Additional patient health information: Female patient , 72 years of age, was diagnosed with histiocytosis haematophagic and. Tazocin dosage: .

6447444-4 | Pneumonia Aspiration, Renal Failure, Septic Shock
Adverse event was reported on Nov 16, 2009 by a Female patient taking Tazocin (View Usage) (Dosage: ) . Location: GERMANY , 20 years of age, After Tazocin was administered, patient had the following side effects: pneumonia aspiration, renal failure, septic shock. Patient was hospitalized.

6435192-6 | Cardiac Arrest, Hypotension, Obstructive Airways Disorder
on Nov 09, 2009 Female patient from UNITED KINGDOM , 78 years of age, was diagnosed with sepsis (What is sepsis?), sedation, deep vein thrombosis (What is deep vein thrombosis?), hypothyroidism, pain (What is pain?), hypertension and was treated with Tazocin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), hypotension, obstructive airways disorder. Tazocin dosage: . During the same period patient was treated with FRUSEMIDE (View Frusemide Review and Frusemide Label ), PROPOFOL (View Propofol Review and Propofol Label ), HEPARIN (View Heparin Review and Heparin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ).

6430353-4 | Autoimmune Thrombocytopenia
on Oct 30, 2009 Male patient from SWEDEN , 64 years of age, was treated with Tazocin (View Usage). Patient had the following side effects: autoimmune thrombocytopenia. Tazocin dosage: .

6396449-0 | Anxiety, Fatigue, Malaise, Pyrexia, Rash, Vomiting
Patient was taking Tazocin (View Usage). After Tazocin was administered, patient had the following side effects: anxiety (What is anxiety?), fatigue, malaise, pyrexia, rash (What is rash?), vomiting on Oct 05, 2009 from UNITED KINGDOM Additional patient health information: Male patient , child 11 years of age, was diagnosed with prophylaxis and. Tazocin dosage: . During the same period patient was treated with FLUCLOXACILLIN (View Flucloxacillin Review and Flucloxacillin Label ). Patient was hospitalized and became disabled.

6371788-8 | Abdominal Discomfort, Acute Myocardial Infarction
Adverse event was reported on Sep 21, 2009 by a Female patient taking Tazocin (View Usage) (Dosage: ) was diagnosed with pyelonephritis and. Location: UNITED KINGDOM , 72 years of age, Patient experienced the following unwanted or unexpected effects: abdominal discomfort, acute myocardial infarction. Patient was hospitalized.

6341906-6 | Muscular Weakness
on Sep 03, 2009 Male patient from UNITED KINGDOM , 21 years of age, was diagnosed with pneumonia (What is pneumonia?), cerebral palsy, epilepsy (What is epilepsy?) and was treated with Tazocin (View Usage). Patient had the following side effects: muscular weakness. Tazocin dosage: . During the same period patient was treated with CYCLIZINE (View Cyclizine Review and Cyclizine Label ), TIZANIDINE HCL (View Tizanidine Hcl Review and Tizanidine Hcl Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), EPILIM (View Epilim Review and Epilim Label ).

6327699-7 | Condition Aggravated, Hypokalaemia, Lower Respiratory Tract Infection
on Aug 24, 2009 Female patient from UNITED KINGDOM , 94 years of age, was diagnosed with lower respiratory tract infection and was treated with Tazocin (View Usage). After Tazocin was administered, patient had the following side effects: condition aggravated, hypokalaemia, lower respiratory tract infection. Tazocin dosage: . During the same period patient was treated with TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), FLUDROCORTISONE (View Fludrocortisone Review and Fludrocortisone Label ), CHLORAMPHENICOL (View Chloramphenicol Review and Chloramphenicol Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ).

6315368-9 | Diarrhoea, Encephalopathy, Vomiting
Patient was taking Tazocin (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, encephalopathy, vomiting on Aug 17, 2009 from SWEDEN Additional patient health information: Male patient , 73 years of age, was diagnosed with diabetic ulcer and. Tazocin dosage: . During the same period patient was treated with INSULATARD (View Insulatard Review and Insulatard Label ), ATACAND HCT (View Atacand Hct Review and Atacand Hct Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SELOKEN (View Seloken Review and Seloken Label ), LASIX (30 Mg) (View Lasix Review and Lasix Label ), DAONIL (3.5) (View Daonil Review and Daonil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6277908-8 | Ankle Fracture, Febrile Neutropenia, Joint Dislocation
Adverse event was reported on Jul 17, 2009 by a Male patient taking Tazocin (View Usage) (Dosage: ) was diagnosed with pseudomonas infection and. Location: UNITED KINGDOM , 42 years of age, weighting 154.3 lb, Patient had the following side effects: ankle fracture, febrile neutropenia, joint dislocation. Patient was hospitalized.

6275108-9 | Ankle Fracture, Febrile Neutropenia, Joint Dislocation
on Jul 17, 2009 Male patient from UNITED KINGDOM , 42 years of age, weighting 154.3 lb, was diagnosed with pseudomonas infection and was treated with Tazocin (View Usage). After Tazocin was administered, patient had the following side effects: ankle fracture, febrile neutropenia, joint dislocation. Tazocin dosage: . Patient was hospitalized.

6267445-9 | Anaphylactic Reaction, Eyelid Oedema, Pruritus
on Jul 09, 2009 Male patient from COLOMBIA , weighting 88.18 lb, was diagnosed with wound infection and was treated with Tazocin (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, eyelid oedema, pruritus. Tazocin dosage: . During the same period patient was treated with TRAMADOL HCL (50 Mg/0.8 Cc) (View Tramadol Hcl Review and Tramadol Hcl Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), DIPIPANONE (30 Mg/kg/day (0.6 Cc Every 6 Hours)) (View Dipipanone Review and Dipipanone Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ). Patient was hospitalized.

6237428-3 | Interstitial Lung Disease
Patient was taking Tazocin (View Usage). Patient had the following side effects: interstitial lung disease on Jun 15, 2009 from JAPAN Additional patient health information: Male patient , 72 years of age, weighting 125.7 lb, was diagnosed with metastatic gastric cancer, adrenal insufficiency and. Tazocin dosage: . During the same period patient was treated with UFT (View Uft Review and Uft Label ), TOPOTECIN (View Topotecin Review and Topotecin Label ), CARBENIN (View Carbenin Review and Carbenin Label ), DECADRON #1 (View Decadron #1 Review and Decadron #1 Label ), DALACIN S (View Dalacin-s Review and Dalacin-s Label ), OMEPRAL (View Omepral Review and Omepral Label ). Patient was hospitalized.

6179807-9 | Hypertension, Paraesthesia, Vomiting
Adverse event was reported on May 01, 2009 by a Female patient taking Tazocin (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 59.52 lb, After Tazocin was administered, patient had the following side effects: hypertension, paraesthesia, vomiting. Patient was hospitalized.

6154207-6 | Blood Pressure Decreased, Erythema, Feeling Abnormal, Rash Macular, Tachycardia
on Apr 07, 2009 Female patient from UNITED KINGDOM , 67 years of age, weighting 131.2 lb, was treated with Tazocin (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, erythema, feeling abnormal, rash macular, tachycardia. Tazocin dosage: .

6140170-0 | Graft Versus Host Disease
on Mar 23, 2009 Male patient from UNITED KINGDOM , 62 years of age, was diagnosed with bacteraemia and was treated with Tazocin (View Usage). Patient had the following side effects: graft versus host disease. Tazocin dosage: . During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ). Patient was hospitalized.

6140128-1 | Chills, Peripheral Coldness, Polymyalgia Rheumatica, Skin Discolouration
Patient was taking Tazocin (View Usage). After Tazocin was administered, patient had the following side effects: chills, peripheral coldness, polymyalgia rheumatica (What is polymyalgia rheumatica?), skin discolouration on Mar 26, 2009 from IRELAND Additional patient health information: Female patient , weighting 185.2 lb, was diagnosed with diverticulitis, pain (What is pain?), nausea (What is nausea?) and. Tazocin dosage: Received Two Doses 4.9g/0.5g 12 Hours Apart. During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), PARACETAMOL (As Required) (View Paracetamol Review and Paracetamol Label ), TRAMADOL HCL (50 Mg As Required) (View Tramadol Hcl Review and Tramadol Hcl Label ), PROCHLORPERAZINE (12.5 Mg As Required) (View Prochlorperazine Review and Prochlorperazine Label ).

6066426-8 | Cardio-respiratory Arrest, Thrombocytopenia
Adverse event was reported on Jan 30, 2009 by a Female patient taking Tazocin (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?), nutritional support (What is nutritional support?), vomiting, prophylaxis against gastrointestinal ulcer and. Location: TURKEY , weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, thrombocytopenia. During the same period patient was treated with TPN (View Tpn Review and Tpn Label ), MEPAMIDE (View Mepamide Review and Mepamide Label ), ULCURAN (View Ulcuran Review and Ulcuran Label ).

6045708-X | Blood Pressure Fluctuation, Chest Discomfort, Nausea, Swelling Face, Urticaria
on Jan 16, 2009 Female patient from UNITED KINGDOM , 19 years of age, weighting 101.4 lb, was diagnosed with bronchiolitis and was treated with Tazocin (View Usage). Patient had the following side effects: blood pressure fluctuation, chest discomfort, nausea (What is nausea?), swelling face, urticaria. Tazocin dosage: . During the same period patient was treated with FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), SERTRALINE (View Sertraline Review and Sertraline Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), FLUDROCORTISONE ACETATE (View Fludrocortisone Acetate Review and Fludrocortisone Acetate Label ).

6045661-9 | Dysstasia, Myalgia
on Jan 16, 2009 Male patient from UNITED KINGDOM , 67 years of age, was diagnosed with oesophageal operation and was treated with Tazocin (View Usage). After Tazocin was administered, patient had the following side effects: dysstasia, myalgia. Tazocin dosage: . During the same period patient was treated with CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), TINZAPARIN SODIUM (View Tinzaparin Sodium Review and Tinzaparin Sodium Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ).

6029671-3 | Abdominal Discomfort, Pancytopenia, Pyrexia
Patient was taking Tazocin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, pancytopenia, pyrexia on Dec 31, 2008 from TURKEY Additional patient health information: Male patient , weighting 205.0 lb, was diagnosed with osteomyelitis and. Tazocin dosage: . During the same period patient was treated with CIPRO (View Cipro Review and Cipro Label ).

6017648-3 | Chest Pain, Pancytopenia, Paraesthesia
Adverse event was reported on Dec 19, 2008 by a Male patient taking Tazocin (View Usage) (Dosage: ) was diagnosed with osteomyelitis and. Location: TURKEY , weighting 154.3 lb, Patient had the following side effects: chest pain (What is chest pain?), pancytopenia, paraesthesia. During the same period patient was treated with CIPRO (View Cipro Review and Cipro Label ).

6016458-0 | Hyperaemia, Syncope
on Dec 17, 2008 Male patient from TURKEY , weighting 176.4 lb, was diagnosed with pseudomonas infection, pain in extremity and was treated with Tazocin (View Usage). After Tazocin was administered, patient had the following side effects: hyperaemia, syncope. Tazocin dosage: . During the same period patient was treated with XANAX (2x 1/2) (View Xanax Review and Xanax Label ), CIPRALEX (1x1) (View Cipralex Review and Cipralex Label ), DICLOFENAC SODIUM (2x 1) (View Diclofenac Sodium Review and Diclofenac Sodium Label ).

6010921-4 | Interstitial Lung Disease
on Dec 09, 2008 Male patient from JAPAN , 72 years of age, weighting 125.7 lb, was diagnosed with metastatic gastric cancer, adrenal insufficiency and was treated with Tazocin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Tazocin dosage: . During the same period patient was treated with UFT (View Uft Review and Uft Label ), TOPOTECIN (View Topotecin Review and Topotecin Label ), CARBENIN (View Carbenin Review and Carbenin Label ), DECADRON #1 (View Decadron #1 Review and Decadron #1 Label ), DALACIN S (View Dalacin-s Review and Dalacin-s Label ), OMEPRAL (View Omepral Review and Omepral Label ). Patient was hospitalized.

6010647-7 | Arthralgia, Feeling Of Body Temperature Change, Headache, Myalgia, Product Quality Issue
Patient was taking Tazocin (View Usage). Patient had the following side effects: arthralgia, feeling of body temperature change, headache (What is headache?), myalgia, product quality issue on Dec 15, 2008 from IRELAND Additional patient health information: Male patient , 20 years of age, weighting 143.7 lb, was diagnosed with infection (What is infection?) and. Tazocin dosage: . During the same period patient was treated with FLOXACILLIN SODIUM (View Floxacillin Sodium Review and Floxacillin Sodium Label ). Patient was hospitalized.

6010495-8 | Septic Shock
Adverse event was reported on Dec 15, 2008 by a Male patient taking Tazocin (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: ISRAEL , 15 years of age, After Tazocin was administered, patient had the following side effects: septic shock. During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ).

6010120-6 | Interstitial Lung Disease
on Dec 09, 2008 Male patient from JAPAN , 72 years of age, weighting 125.7 lb, was diagnosed with metastatic gastric cancer, adrenal insufficiency and was treated with Tazocin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Tazocin dosage: . During the same period patient was treated with UFT (View Uft Review and Uft Label ), TOPOTECIN (View Topotecin Review and Topotecin Label ), CARBENIN (View Carbenin Review and Carbenin Label ), DECADRON #1 (View Decadron #1 Review and Decadron #1 Label ), DALACIN S (View Dalacin-s Review and Dalacin-s Label ), OMEPRAL (View Omepral Review and Omepral Label ). Patient was hospitalized.

5989403-1 | International Normalised Ratio Increased
on Dec 09, 2008 Female patient from UNITED KINGDOM , 66 years of age, weighting 165.3 lb, was diagnosed with urinary tract infection pseudomonal and was treated with Tazocin (View Usage). Patient had the following side effects: international normalised ratio increased. Tazocin dosage: . Patient was hospitalized.

5978237-X | Multi-organ Failure, Sepsis, Toxic Epidermal Necrolysis
Patient was taking Tazocin (View Usage). After Tazocin was administered, patient had the following side effects: multi-organ failure, sepsis (What is sepsis?), toxic epidermal necrolysis on Nov 28, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 18 years of age, weighting 121.3 lb, was diagnosed with meningitis (What is meningitis?), lower respiratory tract infection and. Tazocin dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), CEFOTAXIME SODIUM (View Cefotaxime Sodium Review and Cefotaxime Sodium Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ). Patient was hospitalized.

5967783-0 | Obstructive Airways Disorder, Swollen Tongue
Adverse event was reported on Nov 21, 2008 by a Male patient taking Tazocin (View Usage) (Dosage: ) was diagnosed with sepsis (What is sepsis?) and. Location: UNITED KINGDOM , 56 years of age, weighting 191.1 lb, Patient experienced the following unwanted or unexpected effects: obstructive airways disorder, swollen tongue. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), NICORETTE DS (View Nicorette Ds Review and Nicorette Ds Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PABRINEX (View Pabrinex Review and Pabrinex Label ), RIFAXIMIN (View Rifaximin Review and Rifaximin Label ).

5959058-0 | Hot Flush, Neutropenia, Product Quality Issue, Pyrexia
on Nov 17, 2008 Male patient from IRELAND , 21 years of age, weighting 131.2 lb, was diagnosed with infection (What is infection?) and was treated with Tazocin (View Usage). Patient had the following side effects: hot flush, neutropenia, product quality issue, pyrexia. Tazocin dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ). Patient was hospitalized.

5959057-9 | Arthralgia, Feeling Of Body Temperature Change, Headache, Myalgia, Product Quality Issue
on Nov 17, 2008 Male patient from IRELAND , 20 years of age, weighting 143.7 lb, was diagnosed with infection (What is infection?) and was treated with Tazocin (View Usage). After Tazocin was administered, patient had the following side effects: arthralgia, feeling of body temperature change, headache (What is headache?), myalgia, product quality issue. Tazocin dosage: . During the same period patient was treated with FLOXACILLIN SODIUM (View Floxacillin Sodium Review and Floxacillin Sodium Label ). Patient was hospitalized.

5956386-X | Lip Swelling, Speech Disorder, Swollen Tongue
Patient was taking Tazocin (View Usage). Patient experienced the following unwanted or unexpected effects: lip swelling, speech disorder, swollen tongue on Nov 13, 2008 from CROATIA (local name: Hrvatska) Additional patient health information: Male patient , 58 years of age, was diagnosed with liver abscess and. Tazocin dosage: . During the same period patient was treated with DOXYCYCLINE (2 X 100 G) (View Doxycycline Review and Doxycycline Label ), OCTAGAM (20 Gr) (View Octagam Review and Octagam Label ).

5941906-1 | Blood Creatinine Increased, Renal Disorder
Adverse event was reported on Oct 28, 2008 by a Male patient taking Tazocin (View Usage) (Dosage: ) was diagnosed with pyelonephritis acute and. Location: JAPAN , 75 years of age, Patient had the following side effects: blood creatinine increased, renal disorder. During the same period patient was treated with URALYT U (View Uralyt-u Review and Uralyt-u Label ), CALBLOCK (View Calblock Review and Calblock Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), LASIX (View Lasix Review and Lasix Label ), CELESTAMINE TAB (View Celestamine Tab Review and Celestamine Tab Label ). Patient was hospitalized.

5940876-X | Liver Disorder, Rash
on Oct 30, 2008 Female patient from JAPAN , 75 years of age, was diagnosed with infection prophylaxis and was treated with Tazocin (View Usage). After Tazocin was administered, patient had the following side effects: liver disorder, rash (What is rash?). Tazocin dosage: . During the same period patient was treated with COTRIM (View Cotrim Review and Cotrim Label ). Patient was hospitalized.

5939141-6 | Abnormal Behaviour, Confusional State, Hallucination, Auditory, Paranoia
on Oct 29, 2008 Female patient from UNITED KINGDOM , 49 years of age, was diagnosed with neutropenia, hypothyroidism, depression (What is depression?), hypertension, bladder disorder and was treated with Tazocin (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, confusional state, hallucination, auditory, paranoia. Tazocin dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), PREMARIN (View Premarin Review and Premarin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ). Patient was hospitalized.

5935661-9 | Liver Disorder, Toxic Epidermal Necrolysis
Patient was taking Tazocin (View Usage). Patient had the following side effects: liver disorder, toxic epidermal necrolysis on Oct 23, 2008 from JAPAN Additional patient health information: Female patient , 79 years of age, . Tazocin dosage: 2.5 G - Dosing Interval Not Provided.